Gender Differences in Prevalence of Undiagnosed Diabetes in ACS
This trial is active, not recruiting.
|Collaborator||American Heart Association|
|Start date||October 2001|
|End date||September 2005|
|Trial size||103 participants|
|Trial identifier||NCT00589459, 12258, AHA, Donaghue Women's Health R02524|
The primary goal of this study is to measure the prevalence of undiagnosed pre-diabetes/diabetes among women hospitalized with acute coronary syndromes (ACS) compared to men. Inpatients with confirmed ACS (and no known prior history of diabetes) are invited to return to the Yale Hospital Research Unit 6-8 weeks after hospital discharge for an oral glucose tolerance test to identify individuals with pre-diabetes and diabetes.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
non-diabetic women with acute coronary syndrome (ACS)
non-diabetic men with acute coronary syndrome (ACS)
Prevalence of undiagnosed pre-diabetes or undiagnosed diabetes
time frame: after hospitalization for acute coronary syndrome
Male or female participants at least 30 years old.
Inclusion Criteria: - acute coronary syndrome - age > 30 yrs Exclusion Criteria: - previously diagnosed diabetes - ACS due to substance abuse or trauma
|Official title||A Pilot Study of Gender Differences in the Prevalence of Undiagnosed Diabetes in Acute Coronary Syndromes (ACS)|
|Principal investigator||Barbara I Gulanski, MD, MPH|
Call for more information